Tumor cell-derived IL-8 can stimulate cancer cell proliferation and migration via the autocrine mechanism; and promote the growth and angiogenic ability of endothelial cells and the recruitment of neutrophils to the tumor site via the paracrine mechanism [38, 39]. This evidence concerns the gene CXCL8 and neoplasm.